首页> 外文期刊>Neuroradiology >Early biomarkers from dynamic contrast-enhanced magnetic resonance imaging to predict the response to antiangiogenic therapy in high-grade gliomas
【24h】

Early biomarkers from dynamic contrast-enhanced magnetic resonance imaging to predict the response to antiangiogenic therapy in high-grade gliomas

机译:动态对比增强磁共振成像的早期生物标记物可预测高级别胶质瘤对抗血管生成治疗的反应

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of this study is to investigate whether early changes in tumor volume and perfusion measurements derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) may predict response to antiangiogenic therapy in recurrent high-grade gliomas.
机译:这项研究的目的是调查从动态对比增强磁共振成像(DCE-MRI)获得的肿瘤体积和灌注测量值的早期变化是否可以预测复发性高级别胶质瘤对抗血管生成治疗的反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号